Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

935 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renal transplantation and sleep: a new life is not enough.
Sabbatini M, Pisani A, Crispo A, Nappi R, Gallo R, Cianciaruso B, Federico S. Sabbatini M, et al. Among authors: pisani a. J Nephrol. 2008 Mar-Apr;21 Suppl 13:S97-101. J Nephrol. 2008. PMID: 18446740
Insomnia in maintenance haemodialysis patients.
Sabbatini M, Minale B, Crispo A, Pisani A, Ragosta A, Esposito R, Cesaro A, Cianciaruso B, Andreucci VE. Sabbatini M, et al. Among authors: pisani a. Nephrol Dial Transplant. 2002 May;17(5):852-6. doi: 10.1093/ndt/17.5.852. Nephrol Dial Transplant. 2002. PMID: 11981073
Zaleplon improves sleep quality in maintenance hemodialysis patients.
Sabbatini M, Crispo A, Pisani A, Ragosta A, Cesaro A, Mirenghi F, Cianciaruso B, Federico S. Sabbatini M, et al. Among authors: pisani a. Nephron Clin Pract. 2003;94(4):c99-103. doi: 10.1159/000072493. Nephron Clin Pract. 2003. PMID: 12972720 Clinical Trial.
Sleep quality in renal transplant patients: a never investigated problem.
Sabbatini M, Crispo A, Pisani A, Gallo R, Cianciaruso B, Fuiano G, Federico S, Andreucci VE. Sabbatini M, et al. Among authors: pisani a. Nephrol Dial Transplant. 2005 Jan;20(1):194-8. doi: 10.1093/ndt/gfh604. Epub 2004 Dec 7. Nephrol Dial Transplant. 2005. PMID: 15585511
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.
Sabbatini M, Capone D, Gallo R, Pisani A, Polichetti G, Tarantino G, Gentile A, Rotaia E, Federico S. Sabbatini M, et al. Among authors: pisani a. Fundam Clin Pharmacol. 2009 Oct;23(5):617-24. doi: 10.1111/j.1472-8206.2009.00711.x. Epub 2009 Jul 28. Fundam Clin Pharmacol. 2009. PMID: 19656208 Clinical Trial.
935 results